As of Aug 27
| +0.0121 / +2.75%|
The 4 analysts offering 12-month price forecasts for Mast Therapeutics Inc have a median target of 2.75, with a high estimate of 3.00 and a low estimate of 1.00. The median estimate represents a +508.27% increase from the last price of 0.45.
The current consensus among 5 polled investment analysts is to Buy stock in Mast Therapeutics Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.